Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Anna V. Smirnova"'
Autor:
Natalia V. Pozdniakova, Alexey A. Lipengolts, Vsevolod A. Skribitsky, Kristina E. Shpakova, Yulia A. Finogenova, Anna V. Smirnova, Alexei B. Shevelev, Elena Y. Grigorieva
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 18, p 10197 (2024)
99mTc is a well-known radionuclide that is widely used and readily available for SPECT/CT (Single-Photon Emission Computed Tomography) diagnosis. However, commercial isotope carriers are not specific enough to tumours, rapidly clear from the bloodstr
Externí odkaz:
https://doaj.org/article/4b33c6a9e09241c8bde0a24d1d07073a
Autor:
Natal’ya M. Paramonova, Sergey V. Chepur, Mariya О. Pervak, Vadim A. Myasnikov, Mikhail A. Tyunin, Nikita S. Ilinskiy, Boris A. Kanevskij, Anna V. Smirnova
Publikováno v:
Вопросы вирусологии, Vol 67, Iss 5, Pp 403-413 (2022)
Introduction. Convalescent COVID-19 patients have various signs of central nervous system damage, including those directly associated with SARS-CoV-2. Hence, studies of SARS-COV-2 related morphological changes in neocortex are particularly relevant f
Externí odkaz:
https://doaj.org/article/aa63681b92df414db75a7dfbd71b8f61
Autor:
Tatiana A. Shnaider, Anna A. Khabarova, Ksenia N. Morozova, Anastasia M. Yunusova, Sophia A. Yakovleva, Anastasia S. Chvileva, Ekaterina R. Wolf, Elena V. Kiseleva, Elena V. Grigor’eva, Viktori Y. Voinova, Maria A. Lagarkova, Ekaterina A. Pomerantseva, Elizaveta V. Musatova, Alexander V. Smirnov, Anna V. Smirnova, Diana S. Stoklitskaya, Tatiana I. Arefieva, Daria A. Larina, Tatiana V. Nikitina, Inna E. Pristyazhnyuk
Publikováno v:
Cells, Vol 12, Iss 23, p 2702 (2023)
Cohen syndrome is an autosomal recessive disorder caused by VPS13B (COH1) gene mutations. This syndrome is significantly underdiagnosed and is characterized by intellectual disability, microcephaly, autistic symptoms, hypotension, myopia, retinal dys
Externí odkaz:
https://doaj.org/article/46fae80a53d840f5ae947d70a2822115
Autor:
Alexey A. Lipengolts, Yulia A. Finogenova, Vsevolod A. Skribitsky, Kristina E. Shpakova, Adi Anaki, Menachem Motiei, Alevtina S. Semkina, Maxim A. Abakumov, Anna V. Smirnova, Elena Y. Grigorieva, Rachela Popovtzer
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 1, p 70 (2022)
Gold-containing nanoparticles are proven to be an effective radiosensitizer in the radiotherapy of tumors. Reliable imaging of nanoparticles in a tumor and surrounding normal tissues is crucial both for diagnostics and for nanoparticle application as
Externí odkaz:
https://doaj.org/article/824c6b4c940845328d24000668e86204
Autor:
Olga A. Miteva, Anna V. Smirnova, Irina A. Myasnikova, Ksenia A. Bykova, Boris A. Kanevsky, Vadim A. Myasnikov
Publikováno v:
Bulletin of the Russian Military Medical Academy. 24:675-682
Given the rapid spread of coronavirus disease 2019 (COVID-19) globally, test systems are needed for its diagnosis, timely treatment, and introduction of quarantine measures. In the shortest possible time, a diagnostic system based on real-time revers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0034972b96d6be33f99e55d440cdf1b5
https://doi.org/10.17816/brmma107133
https://doi.org/10.17816/brmma107133
Autor:
Andrey B. Larichev, Anna V. Smirnova, Natalya A. Slobodskaya, Vasiliy B. Kryuchkov, Andrey A. Vasiliev, Nikita M. Izyumov
Publikováno v:
Человек и его здоровье. 25:60-71
Objective: to develop a method for verifying ceftriaxone and determining its concentration in blood serum by means of capillary electrophoresis. Materials and methods. The study used ceftriaxone sodium salt (CJSC Pharmaceutical Company "Lekko"), mode
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be31642574d0eb82f6db208b057c50a4
https://doi.org/10.21626/vestnik/2022-3/07
https://doi.org/10.21626/vestnik/2022-3/07
Publikováno v:
Транспорт наука техника управление. :18-24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81f28637d53eba44f8e1a70248c509c6
https://doi.org/10.36535/0236-1914-2022-11-3
https://doi.org/10.36535/0236-1914-2022-11-3
Autor:
Anna V. Smirnova, Yulia А. Kuznetsova
Publikováno v:
City Healthcare. 2:101-108
Purpose. To evaluate clinical trials data since January 2021 till March 2021. Materials and methods. The information about clinical trial’s approvals from the state register of medicines of Russian Federation ministry of health website was used as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be6b9778f15408980f41c74d18c701ed
https://doi.org/10.47619/2713-2617.zm.2021.v2i2
https://doi.org/10.47619/2713-2617.zm.2021.v2i2